32
Participants
Start Date
June 29, 2016
Primary Completion Date
June 20, 2017
Study Completion Date
June 20, 2017
Gepotidacin
Gepotidacin after reconstitution is a clear, dark brown to dark brownish-yellow solution, free from visible particulate matter. Subjects will receive gepotidacin 750 mg single IV dose over 2 hours.
GSK Investigational Site, Orlando
GSK Investigational Site, Miami
GSK Investigational Site, Minneapolis
Lead Sponsor
GlaxoSmithKline
INDUSTRY